Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (8.2), the stock would be worth kr0.17 (108% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.9 | kr0.08 |
0%
|
| 3-Year Average | 8.2 | kr0.17 |
+108%
|
| 5-Year Average | 5 | kr0.1 |
+28%
|
| Industry Average | 0.9 | kr0.02 |
-77%
|
| Country Average | 2.3 | kr0.05 |
-42%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| DK |
|
Pharma Equity Group A/S
CSE:PEG
|
100.2m DKK | 3.9 | -3.9 | |
| DE |
|
Vonovia SE
XETRA:VNA
|
19.5B EUR | 0.7 | 5.2 | |
| IL |
|
Azrieli Group Ltd
TASE:AZRG
|
56B ILS | 2.2 | 29.7 | |
| HK |
S
|
Swire Properties Ltd
HKEX:1972
|
143B HKD | 0.5 | -92.4 | |
| BM |
|
Hongkong Land Holdings Ltd
SGX:H78
|
16.4B USD | 0.5 | 12.8 | |
| CH |
|
Swiss Prime Site AG
SIX:SPSN
|
10.9B CHF | 1.6 | 28.7 | |
| CN |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
107.6B HKD | 6 | 23.5 | |
| SG |
|
Capitaland Investment Ltd
SGX:9CI
|
14.2B SGD | 1.1 | 98 | |
| CN |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
74.7B CNY | 3.3 | 17.8 | |
| CL |
P
|
Plaza SA
SGO:MALLPLAZA
|
9.7T CLP | 2.2 | 6.8 | |
| PH |
S
|
SM Prime Holdings Inc
XPHS:SMPH
|
578.8B PHP | 1.2 | 11.9 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 1.5 |
| Median | 2.3 |
| 70th Percentile | 4.5 |
| Max | 44.6 |
Other Multiples
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
